Product details
Survodutide
Explore Survodutide amounts, pricing, and product information.
Select your product
10mg · 1 unit · Total
Currently unavailable
For laboratory research only. Not for human or veterinary use. Research-use policy.
Know your compound
Compound information
Survodutide
Survodutide is also indexed with the research identifier BI456906.
Identity references 1 source
- Catalog identity
- Survodutide
- Intended use
- Laboratory research
- Reference molecule
- Survodutide
- PubChem record
- CID 168429725
- Molecular formula
- C192H289N47O61
- Molecular weight
- 4232 g/mol
Molecular data describe the reference compound in PubChem, not a laboratory analysis of this product or batch.
Primary literature
Verified research references
Primary-source bibliography for the named compound. These studies did not test this catalog item.
Randomized human research included
Survodutide2 verified references
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial.
le Roux CW · 2024 · Lancet Diabetes Endocrinol
- Study design
- Randomized controlled trial
- Research context
- Human research
- Study population
- People with obesity
PMID: 38330987
DOI: 10.1016/S2213-8587(23)00356-X
Survodutide Once Weekly for the Treatment of Adults with Obesity.
le Roux CW · 2026 · N Engl J Med
- Study design
- Randomized controlled trial
- Research context
- Human research
- Study population
- Adults with obesity
PMID: 42253238
DOI: 10.1056/NEJMoa2600751
Bibliographic references do not establish the identity, purity, safety, effectiveness, or suitability of this catalog item and are not use guidance. For legitimate laboratory and research use only; not for human or veterinary use.
Related catalog
